🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Addus HomeCare stock target raised on strong 1Q24 EBITDA

EditorNatashya Angelica
Published 09/05/2024, 16:00
ADUS
-

On Thursday, TD Cowen adjusted their price target on shares of Addus HomeCare (NASDAQ:ADUS), increasing it to $119.00 from the previous target of $105.00. The firm has maintained its Buy rating on the stock.

The upward revision in the price target follows Addus HomeCare's first-quarter earnings report, which showed the company's EBITDA surpassing consensus estimates by 7%. The better-than-expected performance has prompted TD Cowen to revise their annual estimates for 2024 upwards by 5% and for 2025 by 4%.

The analyst from TD Cowen attributed the positive adjustment to two main factors: improved general and administrative (G&A) leverage and higher Personal Care Services (PCS) rates. These elements have contributed to the company's strong financial results and have led to the raised price target.

In their commentary, the analyst emphasized the company's performance and the reasons behind the positive outlook. "ADUS posted a 1Q24 EBITDA result 7% better than consensus. We are raising our annual estimates in 2024 by 5% and 2025 by 4% mainly on better than expected G&A leverage and higher PCS rates. We raise our price target to 119 and reiterate our Buy rating."

Addus HomeCare's stock price target increase reflects the firm's confidence in the company's growth trajectory and operational efficiency. The maintained Buy rating alongside the raised target suggests that the firm views the stock as a favorable investment option.

InvestingPro Insights

Following the positive sentiment from TD Cowen, InvestingPro data and tips further support the optimistic outlook for Addus HomeCare (NASDAQ:ADUS). The company's market capitalization stands at a robust $1.72 billion, with a P/E ratio of 26.04, which is deemed attractive in relation to its near-term earnings growth.

Moreover, Addus HomeCare's recent performance includes a significant return over the last week, with a price total return of 8.82%, and a notable six-month price total return of 29.66%, indicating strong market confidence.

InvestingPro Tips highlight that four analysts have revised their earnings upwards for the upcoming period, suggesting a consensus view of the company's growth potential. The company's valuation implies a strong free cash flow yield, and its cash flows can sufficiently cover interest payments, which is a reassuring sign for investors concerned about financial stability.

For investors keen on exploring further insights, there are additional InvestingPro Tips available that delve into the company's moderate level of debt, trading patterns, and profitability forecasts. To access these valuable insights and make more informed investment decisions, visit https://www.investing.com/pro/ADUS and use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.